The innate immune response in reperfused myocardium
2012/01/20 by Leo Timmers, L. Timmers, Gerard Pasterkamp +9 · 26 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Cardiac Ischemia and Reperfusion #Extracellular vesicles in disease #Cardiac Fibrosis and Remodeling
paper · pdf · doi:10.1093/cvr/cvs018
Abstract
One of the major therapeutic challenges in the arena of interventional cardiology is to design strategies aimed at reducing myocardial tissue damage after myocardial infarction. In response to tissue injury, an innate immune response is initiated that orchestrates homeostatic responses and is a prerequisite for subsequent wound healing. An exaggerated inflammatory reaction, however, countervenes these beneficial effects and contributes to maladaptive tissue damage. Herein, we discuss the pathways involving the innate immune system that have been investigated in the setting of myocardial ischaemia and reperfusion injury. Endogenous 'danger' signals [danger-associated molecular patterns (DAMPs)] are expressed following tissue injury and alert the innate immune system. Toll-like receptors and the complement system are activated, resulting in an inflammatory reaction involving inflammatory cell influx and the production and release of inflammatory cytokines. A potential involvement of cell-derived microparticles in the modulation of the innate immune response following myocardial injury will also be discussed. Our future challenge lies within the counteraction of maladaptive inflammatory cascades, without interfering in the benign wound healing response, and in translating these anti-inflammatory strategies into clinical practice.
Citations
Cited by
- Acute administration of the olive constituent, oleuropein, combined with ischemic postconditioning increases myocardial protection by modulating oxidative defense
- C/EBP transcription factors mediate epicardial activation during heart development and injury. [europepmc]
- Neutrophil roles in left ventricular remodeling following myocardial infarction. [europepmc]
- The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. [europepmc]
- Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis. [europepmc]
- Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. [europepmc]
- The inflammatory response in myocardial injury, repair, and remodelling. [europepmc]
- Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. [europepmc]
- Wnt10b Gain-of-Function Improves Cardiac Repair by Arteriole Formation and Attenuation of Fibrosis. [europepmc]
- BET protein inhibition mitigates acute myocardial infarction damage in rats via the TLR4/TRAF6/NF-κB pathway. [europepmc]
- The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. [europepmc]
- New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types. [europepmc]
- MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7. [europepmc]
- Innate immunity as a target for acute cardioprotection. [europepmc]
- Immune responses in cardiac repair and regeneration: a comparative point of view. [europepmc]
- Selectins and Immune Cells in Acute Myocardial Infarction and Post-infarction Ventricular Remodeling: Pathophysiology and Novel Treatments. [europepmc]
- The Role of Traditional Chinese Medicine in the Regulation of Oxidative Stress in Treating Coronary Heart Disease. [europepmc]
- Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury from Oxidative Stress by Regulating Succinate, Lysophospholipid Metabolism, and ROS Scavenging System. [europepmc]
- Neutrophil proteome shifts over the myocardial infarction time continuum. [europepmc]
- Ischemia/Reperfusion Injury: Pathophysiology, Current Clinical Management, and Potential Preventive Approaches. [europepmc]
- Monocyte recruitment and fate specification after myocardial infarction. [europepmc]
- The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction. [europepmc]
- Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs. [europepmc]
- Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer. [europepmc]
- Single-cell RNA sequencing reveals S100a9 hi macrophages promote the transition from acute inflammation to fibrotic remodeling after myocardial ischemia‒reperfusion. [europepmc]
- Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities. [europepmc]
Related